LAMASSU BIO INC
SA53, a novel MDM2 inhibitor small molecule therapeutic for p53 wild-type cancers
- Sector
- Biotech
- Headquarters
- Durham, NC
- Total capital
- $2M
- Federal grants
- $2M
- 2 awards · 2023–2024
- Rank in peer group#24 of 326
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Development of a novel small molecule MDM2 inhibitor for innovative sarcoma treatment$723K
- Federal grantHealth and Human S · Phase II · Development of a novel small molecule MDM2 inhibitor for innovative sarcoma treatment$1.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1081 | Zivo Bioscience, Inc. | — | $9.1M |
| 1082 | Forward Therapeutics | — | — |
| 1083 | BIOHELIX CORPORATION | — | — |
| 1084 | LAMASSU BIO INC | — | — |
| 1085 | RERX THERAPEUTICS, INC | — | — |
| 1086 | MOLECULAR INTELLIGENCE LLC | — | — |
| 1087 | ENVISBIO LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
No people are linked to this company yet.
People appear here when they are named as related persons in the company's own Form D filings. We don't infer people from social profiles.
Checked: SEC EDGAR Form D related persons through
Patents
No patents are on record under this company's name.
USPTO publishes applications about 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won't match.
Checked: USPTO granted patents and published applications
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.